SCHEMBL7420399

SCHEMBL7420399

CS(=O)(=O)OCc1ccc(OS(C)(=O)=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 5/20 0.47
CA9 Q16790 3/20 0.47
CA1 P00915 2/20 0.44
PPARG P37231 3/20 0.43
MMP2 P08253 2/20 0.42
MMP7 P09237 2/20 0.42
MMP9 P14780 2/20 0.42
MMP14 P50281 2/20 0.42
MMP1 P03956 1/20 0.42
STS P08842 1/20 0.42
APLNR P35414 1/20 0.42
MMP3 P08254 1/20 0.40
MMP8 P22894 1/20 0.40
IDO1 P14902 2/20 0.39
AGXT P21549 2/20 0.39
PPARA Q07869 3/20 0.39
ALDH1A1 P00352 2/20 0.39
CA12 O43570 2/20 0.38
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4952656 0.87 CA2 (0.58) CA2CA9CA1MMP9APLNR
SCHEMBL5937187 0.84 APLNR (0.59) CA2CA9CA1APLNRIDO1
SCHEMBL3838706 0.81 STS (0.63) CA2CA9CA1PPARGMMP2
SCHEMBL19845815 0.81 CA2 (0.52) CA2CA9CA1MMP9APLNR
SCHEMBL20743498 0.81 NQO1 (0.52) CA2CA9CA1ALDH1A1CA12
SCHEMBL979920 0.81 PPARA (0.49) CA2CA9CA1PPARGMMP2
SCHEMBL7167112 0.80 CA2 (0.39) CA2CA9CA1MMP2MMP7
SCHEMBL575589 0.80 CA2 (0.52) CA2CA9CA1MMP2MMP7
SCHEMBL24041811 0.79 PPARG (0.40) CA2CA9CA1PPARGMMP2
SCHEMBL2254857 0.79 POLB (0.50) CA2CA9CA1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116194439-A SOCE inhibitors and therapeutic uses thereof 国家医疗保健研究所 2023-05-30 CN disclosed
EP-4157822-A1 SOCE INHIBITORS AND THERAPEUTIC USES THEREOF Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2023-04-05 EP disclosed
WO-2021233994-A1 SOCE INHIBITORS AND THERAPEUTIC USES THEREOF INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2021-11-25 WO disclosed
EP-3912972-A1 SOCE INHIBITORS AND THERAPEUTIC USES THEREOF Centre Hospitalier Régional et Universitaire de Brest (FR) 2021-11-24 EP disclosed
WO-1996036595-A1 3,4-DISUBSTITUTED-PHENYLSULPHONAMIDES AND THEIR THERAPEUTIC USE CHIROSCIENCE LIMITED (GB) 1996-11-21 WO disclosed